Standard Biotools Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| 2.1 | 2.0 | 1.7 | 1.2 | 1.7 | 2.2 | 2.2 | 2.2 | 2.7 | 3.2 | 6.6 | 7.1 | 2.7 | 2.1 | 1.5 | 2.5 | 4.3 | 3.2 | 2.3 | 3.2 | 3.7 | 2.3 | 2.2 | 1.1 | 0.8 | 1.0 | 1.6 | 1.4 | 2.2 | 1.6 | 6.3 | 5.5 | 5.0 | 4.2 | 3.1 | 3.4 | 4.6 | 5.9 | 4.1 | 3.8 | |
| 3.4 | 4.0 | 4.3 | 4.9 | 4.4 | 7.4 | 4.6 | 6.7 | 13.1 | 4.9 | 4.3 | 4.9 | 2.0 | 1.6 | 1.2 | 2.1 | 3.5 | 3.2 | 2.7 | 4.3 | 5.1 | 3.2 | 12.5 | – | – | – | – | – | – | 1.1 | 1.4 | 1.3 | 1.4 | 1.4 | 0.9 | 1.1 | 1.2 | 1.2 | 0.6 | 0.6 | |
| – | – | – | – | – | – | – | – | – | – | 6.1 | 6.9 | 2.5 | 1.9 | 1.2 | 2.2 | 3.7 | 2.8 | 2.4 | 3.3 | 4.0 | 2.6 | 2.8 | 1.1 | 0.9 | 0.8 | 1.2 | 0.7 | 2.1 | 1.8 | 4.5 | 3.8 | 3.9 | 3.2 | 2.0 | 2.3 | 3.4 | 4.5 | 1.1 | 0.7 | |
| -19.4% | -20.8% | -26.6% | -37.5% | -21.8% | -11.3% | -14.5% | -12.3% | -8.3% | -7.2% | -3.8% | -3.6% | -10.1% | -15.5% | -12.9% | -7.3% | -3.7% | -6.3% | -12.7% | -12.4% | -12.8% | -19.2% | -19.5% | -53.0% | -93.0% | -97.8% | -54.5% | -43.8% | -22.6% | -26.3% | -12.6% | -19.5% | -21.0% | -22.5% | -29.8% | -23.1% | -19.8% | -16.5% | -26.5% | -25.8% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| 57.0% | 55.9% | 54.5% | 53.0% | 51.9% | 51.0% | 51.0% | 51.3% | 52.7% | 54.6% | 55.3% | 56.0% | 55.7% | 54.8% | 55.5% | 56.6% | 59.5% | 60.3% | 59.9% | 58.7% | 55.0% | 53.1% | 50.3% | 45.1% | 42.2% | 37.8% | 38.4% | 43.9% | 45.8% | 47.4% | 49.1% | 48.6% | 50.4% | 49.9% | 49.5% | 50.0% | 49.0% | 48.5% | 48.3% | 49.1% | |
| -62.8% | -70.1% | -71.2% | -72.6% | -67.8% | -57.3% | -52.6% | -47.8% | -42.2% | -42.6% | -42.2% | -43.1% | -45.9% | -44.2% | -45.8% | -45.9% | -34.4% | -36.9% | -38.7% | -39.8% | -53.4% | -51.7% | -60.9% | -86.5% | -97.4% | -118.6% | -109.0% | -79.8% | -72.6% | -72.0% | -94.8% | -109.4% | -101.7% | -97.0% | -88.5% | -84.1% | -96.3% | -109.3% | -91.0% | -94.8% | |
| -64.6% | -72.8% | -72.6% | -74.0% | -68.3% | -59.4% | -55.7% | -53.7% | -50.5% | -52.2% | -60.5% | -57.5% | -57.1% | -55.3% | -48.2% | -48.5% | -37.8% | -38.4% | -39.0% | -40.5% | -49.5% | -45.4% | -93.9% | -145.6% | -163.6% | -194.1% | -135.3% | -79.8% | -72.0% | -70.2% | -71.0% | -97.6% | -88.2% | -87.0% | -98.8% | -90.1% | -118.5% | -87.8% | -109.1% | -103.3% | |
| -40.9% | -42.3% | -44.0% | -45.5% | -37.8% | -25.2% | -32.3% | -27.6% | -22.6% | -22.6% | -25.2% | -25.7% | -27.6% | -32.2% | -19.8% | -18.4% | -15.6% | -20.4% | -29.7% | -39.1% | -47.0% | -43.9% | -43.4% | -58.9% | -73.9% | -95.1% | -89.3% | -62.1% | -49.4% | -43.4% | -78.8% | -107.5% | -105.2% | -95.0% | -92.2% | -78.9% | -90.9% | -96.9% | -109.5% | -97.6% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -104.7% | -142.7% | -190.4% | -299.2% | -173.5% | -195.7% | -116.5% | -160.4% | -244.0% | -81.8% | -39.1% | -39.8% | -41.1% | -42.2% | -39.1% | -41.1% | -31.4% | -38.1% | -45.4% | -54.8% | -68.3% | -62.6% | -527.8% | – | – | – | – | – | – | -45.7% | -15.6% | -23.3% | -25.5% | -29.4% | -29.2% | -28.4% | -32.1% | -17.7% | -16.8% | -16.2% | |
| -22.2% | -24.8% | -25.1% | -25.7% | -23.2% | -21.1% | -21.0% | -21.6% | -21.7% | -19.4% | -24.4% | -24.2% | -24.8% | -24.5% | -19.1% | -19.3% | -14.8% | -16.3% | -18.3% | -20.7% | -24.0% | -21.5% | -42.9% | -37.0% | -43.1% | -48.7% | -35.2% | -23.7% | -22.3% | -23.1% | -11.6% | -16.7% | -18.3% | -22.7% | -22.9% | -21.6% | -23.8% | -13.2% | -14.7% | -13.9% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | -62 | -21 | -24 | -20 | -34 | -41 | -70 | -66 | 7.1 | 26 | 38 | 46 | 73 | -6.5 | 8.0 | -13 | -45 | -73 | -11 | 16 | -226 | -209 | -149 | -160 | -144 | -153 | -124 | -112 | -260 | -264 | |
| 21.2% | 17.4% | 13.2% | 8.6% | 13.4% | 10.8% | 18.0% | 13.4% | 8.9% | 23.7% | 62.5% | 60.8% | 60.4% | 58.0% | 48.8% | 47.0% | 47.1% | 42.8% | 40.3% | 37.8% | 35.2% | 34.4% | 8.1% | -8.5% | -15.1% | -20.9% | -26.1% | -31.9% | -38.8% | 50.5% | 74.2% | 72.0% | 71.8% | 77.0% | 78.4% | 76.2% | 74.1% | 74.7% | 87.8% | 86.1% | |
| – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.7 | 0.8 | 4.7 | – | – | – | – | – | – | 0.4 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -2.45 | -2.61 | -2.51 | -2.44 | -1.96 | -1.56 | -1.46 | -1.43 | -1.39 | -1.42 | -1.22 | -0.99 | -0.96 | -0.93 | -0.78 | -0.77 | -0.66 | -0.71 | -0.75 | -0.80 | -0.89 | -0.77 | -1.52 | -2.10 | -2.26 | -2.39 | -1.65 | -1.07 | -0.96 | -0.94 | -0.31 | -0.32 | -0.34 | -0.37 | -0.35 | -0.32 | -0.34 | -0.19 | -0.24 | -0.22 | |
| 3.79 | 3.58 | 3.45 | 3.30 | 2.88 | 2.63 | 2.62 | 2.67 | 2.76 | 2.72 | 2.02 | 1.73 | 1.69 | 1.68 | 1.63 | 1.59 | 1.74 | 1.86 | 1.92 | 1.97 | 1.79 | 1.70 | 1.61 | 1.44 | 1.38 | 1.23 | 1.22 | 1.34 | 1.33 | 1.33 | 0.43 | 0.33 | 0.38 | 0.43 | 0.36 | 0.35 | 0.28 | 0.22 | 0.22 | 0.22 | |
| 2.34 | 1.83 | 1.32 | 0.82 | 1.13 | 0.80 | 1.25 | 0.89 | 0.57 | 1.74 | 3.12 | 2.50 | 2.34 | 2.20 | 2.01 | 1.87 | 2.10 | 1.87 | 1.65 | 1.45 | 1.30 | 1.23 | 0.29 | -0.48 | -0.80 | -1.03 | -1.23 | -1.44 | -1.66 | 2.05 | 1.96 | 1.37 | 1.32 | 1.26 | 1.20 | 1.12 | 1.04 | 1.10 | 1.45 | 1.38 | |
| -1.55 | -1.51 | -1.52 | -1.50 | -1.09 | -0.66 | -0.84 | -0.74 | -0.62 | -0.62 | -0.51 | -0.44 | -0.47 | -0.54 | -0.32 | -0.29 | -0.27 | -0.38 | -0.57 | -0.77 | -0.84 | -0.75 | -0.70 | -0.85 | -1.02 | -1.17 | -1.09 | -0.83 | -0.66 | -0.58 | -0.34 | -0.35 | -0.40 | -0.41 | -0.33 | -0.28 | -0.26 | -0.21 | -0.24 | -0.21 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.